Purchase Order HT941023P0009
- Not listed
- The Defense Health Agency awarded a $428,650 firm fixed-price purchase order to National Jewish Health for beryllium lymphocyte proliferation test services, with an ultimate completion date of January 31, 2031. The contract was awarded on February 1, 2026, with no set-aside designation applied. Performance will be conducted at Joint Base Pearl Harbor-Hickam in Hawaii. National Jewish Health, a non-profit hospital and research center headquartered in Denver, Colorado, specializes in...
- This is a $13,931.11 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to National Jewish Health, a non-profit hospital and research center based in Denver, Colorado. The contract, which has no set-aside designation, is for the provision of specialized laboratory services to support federal agencies. National Jewish Health has a history of providing services such as acid fast bacilli testing for the Department of Veterans Affairs and beryllium...
- This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) to the non-profit hospital and research center National Jewish Health. The contract is a Definitive Contract with a Cost No Fee pricing type, and has a potential value of $67,944.99. National Jewish Health provides a range of specialized services to federal agencies, including diagnostic testing, animal research services, clinical trial support, and medical research. This contract...
- This is a definitive contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to National Jewish Health, a non-profit hospital and research center, to provide research laboratory animal services. The contract has a firm-fixed price of $538,205.54 and a completion date of August 31, 2021. It was awarded on September 28, 2017 and does not have a set-aside designation. National Jewish Health has provided a range of goods and services to federal agencies...
- The Defense Health Agency awarded Laboratory Corporation of America (Labcorp) a $876,000 firm fixed-price delivery order for clinical reference laboratory testing services at Nellis Air Force Base, Nevada, with performance extending through September 30, 2026. This delivery order, issued without set-aside designation, represents a child contract under a larger Defense Health Agency vehicle that provides streamlined procurement of diagnostic testing services across military medical facilities....
- The Defense Health Agency awarded a $828,024.90 firm fixed price delivery order to Biofire Defense LLC under an unspecified contract vehicle. The order is for respiratory panel testing services to support DHA programs. Work will be performed in Salt Lake City, Utah through December 31, 2021. The prime contractor will provide respiratory disease diagnostic panels to assist the Defense Health Agency in monitoring the health of military personnel. No subcontractors or set-aside designations were...
- This is a cost-no-fee delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to National Jewish Health, a non-profit hospital and research center in Denver, Colorado. The contract, titled "LUNG TISSUE RESEARCH CONSORTIUM: TISSUE REPOSITORY," has a ceiling value of $338,145.22 and a period of performance from January 1, 2016, to December 31, 2020. The contract is not set-aside and is part of the...
- The Defense Health Agency awarded a $14,983.68 Blanket Purchase Agreement (BPA) call to Phadia US Inc.'s Immunodiagnostics Division on January 17, 2026, for test and measurement supplies for medical laboratory use. The contract, which carries a firm fixed price structure with no set-aside designation, will be performed in Portage, Michigan, and is scheduled for completion by September 30, 2026. Phadia US Inc., a foreign-owned subsidiary of Thermo Fisher Scientific, specializes in advanced...
- This $79,000 firm fixed-price purchase order was awarded on July 3, 2019 by the Centers for Disease Control and Prevention (CDC) to National Jewish Health, a non-profit hospital and research center in Denver, Colorado. The contract is for HRCT scans and a computer algorithm, with a period of performance through February 12, 2025. National Jewish Health is an experienced federal contractor, holding several indefinite delivery vehicles (IDVs) with the National Heart, Lung, and Blood Institute...
- The Defense Health Agency awarded Phadia US Inc. a firm fixed-price purchase order valued at $596,483.76 for allergy testing analyzers and reagents to support the Core Laboratory at Tripler Army Medical Center in Hawaii. The contract, which was awarded on October 1, 2023, with an ultimate completion date of September 30, 2026, covers FY24 and FY26 funding and does not utilize a set-aside designation. Phadia US Inc., the Immunodiagnostics Division of Thermo Fisher Scientific, is a specialized...
The Defense Health Agency awarded a $244.4K firm-fixed-price purchase order to National Jewish Health for beryllium lymphocyte proliferation testing services. The contract, effective January 31, 2023, extends through January 31, 2026, with performance taking place at Joint Base Pearl Harbor Hickam, Hawaii. No set-aside designation was utilized for this award. National Jewish Health, a Denver-based nonprofit hospital and research institution, specializes in respiratory and immunological diagnostics and has an established track record providing specialized laboratory testing services to federal health agencies. Beryllium lymphocyte proliferation testing is a diagnostic procedure used to identify beryllium sensitization and chronic beryllium disease, conditions of concern in occupational health settings including military installations. The Defense Health Agency utilizes such testing to support occupational health screening and medical surveillance for potentially exposed personnel. National Jewish Health's expertise in advanced immunological testing and its existing relationships with federal agencies position it well to deliver these specialized laboratory services to military health beneficiaries at the Hawaii installation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $80.8k | 1/8/25 | |
| P00001 | Exercise an Option | $76.6k | 12/18/23 | |
| Not listed | Not listed | $87.0k | 1/30/23 |